| Literature DB >> 25552418 |
Tobin M Abraham1, Karol M Pencina2, Michael J Pencina3, Caroline S Fox4.
Abstract
OBJECTIVE: Obesity and type 2 diabetes continue to increase in prevalence in the U.S. Whether diabetes incidence continues to increase in recent times is less well documented. We examined trends in diabetes incidence over the previous four decades. RESEARCH DESIGN AND METHODS: Framingham Heart Study participants ages 40-55 years and free of diabetes at baseline (n = 4,795; mean age 45.3 years; 51.6% women) were followed for the development of diabetes in the 1970s, 1980s, 1990s, and 2000s. Diabetes was defined as either fasting glucose ≥126 mg/dL or use of antidiabetes medication. Poisson regression was used to calculate sex-specific diabetes incidence rates for a 47-year-old individual in each decade. Rates were also calculated among obese, overweight, and normal weight individuals.Entities:
Mesh:
Year: 2014 PMID: 25552418 PMCID: PMC4338506 DOI: 10.2337/dc14-1432
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112
Baseline characteristics and annualized rates of incident diabetes for a 47-year-old individual
| 1970s | 1980s | 1990s | 2000s | |
|---|---|---|---|---|
| Women, | 656 | 786 | 862 | 889 |
| Age, years | 46 (4) | 47 (5) | 47 (4) | 46 (4) |
| BMI, kg/m2 | 25.0 (4.3) | 24.8 (4.5) | 25.6 (5.3) | 26.4 (6.0) |
| Incident diabetes, | 13 | 24 | 32 | 19 |
| Annualized rate per 1,000 (95% CI) | 2.6 (1.5–4.5) | 3.8 (2.5–5.7) | 4.7 (3.3–6.7) | 3.6 (2.3–5.6) |
| Men, | 652 | 765 | 801 | 803 |
| Age, years | 46 (4) | 47 (5) | 47 (4) | 46 (4) |
| BMI, kg/m2 | 26.9 (3.2) | 27.0 (3.4) | 27.8 (3.9) | 28.0 (4.3) |
| Incident diabetes, | 17 | 28 | 48 | 36 |
| Annualized rate per 1,000 (95% CI) | 3.4 (2.1–5.5) | 4.5 (3.1–6.6) | 7.4 (5.5–9.9) | 7.5 (5.4–10.5) |
| Overall, | 1,308 | 1,551 | 1,663 | 1,692 |
| Incident diabetes, | 30 | 52 | 80 | 55 |
| Annualized rate per 1,000 (95% CI) | 3.0 (2.1–4.3) | 4.1 (3.2–5.5) | 6.0 (4.8–7.5) | 5.5 (4.2–7.1) |
Data are mean (SD) or n unless otherwise indicated.
Overall sample included 2,476 unique women and 2,319 unique men; some individuals were included in more than one decade.
Relative risks of incident diabetes for individuals ages 40–55 years free of diabetes in the 1980s, 1990s, and 2000s compared with the 1970s
| Age-adjusted RR (95% CI) | RR with age and BMI adjustment (95% CI) | |||
|---|---|---|---|---|
| Overall | ||||
| 1970s | Ref | 1 | ||
| 1980s | 1.37 (0.87–2.16) | 0.17 | 1.34 (0.85–2.11) | 0.20 |
| 1990s | 1.99 (1.30–3.03) | <0.01 | 1.58 (1.03–2.42) | 0.04 |
| 2000s | 1.81 (1.16–2.82) | 0.01 | 1.32 (0.84–2.08) | 0.22 |
| Women | ||||
| 1970s | Ref | Ref | ||
| 1980s | 1.45 (0.74–2.86) | 0.28 | 1.42 (0.72–2.80) | 0.31 |
| 1990s | 1.80 (0.94–3.44) | 0.08 | 1.40 (0.72–2.70) | 0.32 |
| 2000s | 1.37 (0.67–2.78) | 0.38 | 0.96 (0.47–1.97) | 0.92 |
| Men | ||||
| 1970s | Ref | Ref | ||
| 1980s | 1.32 (0.72–2.42) | 0.36 | 1.29 (0.71–2.37) | 0.40 |
| 1990s | 2.16 (1.24–3.76) | <0.01 | 1.68 (0.95–2.95) | 0.07 |
| 2000s | 2.20 (1.24–3.92) | <0.01 | 1.52 (0.84–2.75) | 0.16 |
Ref, referent; RR, relative risk.
Figure 1Annualized rates of diabetes per 1,000 individuals. Age-adjusted annualized rates of diabetes for a 47-year-old per 1,000 individuals, stratified by normal, overweight, or obese BMI. Error bars represent 95% CIs. Number of participants at risk in the normal, overweight, and obese categories, respectively, in the 1970s were 585, 542, and 181; in the 1980s: 721, 604, and 226; in the 1990s: 671, 654, and 338; in the 2000s: 651, 637, and 404.
Annualized rates of diabetes by BMI category for a 47-year-old individual
| 1970s | 1980s | 1990s | 2000s | |
|---|---|---|---|---|
| Normal weight (BMI <25 kg/m2), | 585 | 721 | 671 | 651 |
| BMI, mean (SD) | 22.7 (1.6) | 22.5 (1.7) | 22.5 (1.7) | 22.4 (1.7) |
| Incident diabetes, | 2 | 8 | 7 | 6 |
| Annualized rate, per 1,000 individuals (95% CI) | 0.5 (0.1–1.8) | 1.4 (0.7–2.8) | 1.3 (0.6–2.8) | 1.6 (0.7–3.5) |
| Overweight (BMI 25 to <30 kg/m2), | 542 | 604 | 654 | 637 |
| BMI, mean (SD) | 27.1 (1.4) | 27.2 (1.4) | 27.3 (1.4) | 27.3 (1.4) |
| Incident diabetes, | 17 | 26 | 30 | 14 |
| Annualized rate, per 1,000 individuals (95% CI) | 4.1 (2.6–6.6) | 5.2 (3.5–7.7) | 5.6 (3.9–8.1) | 3.7 (2.2–6.2) |
| Class 1 obesity (BMI 30 to <35 kg/m2), | 149 | 185 | 256 | 265 |
| BMI, mean (SD) | 31.9 (1.4) | 31.9 (1.3) | 32.0 (1.3) | 32.0 (1.4) |
| Incident diabetes, | 8 | 12 | 29 | 12 |
| Annualized rate, per 1,000 individuals (95% CI) | 7.0 (3.5–13.9) | 8.0 (4.5–14.2) | 14.1 (9.7–20.5) | 7.5 (4.3–13.2) |
| Class 2 obesity (BMI ≥35 kg/m2), | 32 | 41 | 82 | 139 |
| BMI, mean (SD) | 37.7 (3.4) | 38.8 (3.1) | 39.5 (4.4) | 39.3 (4.1) |
| Incident diabetes, | 3 | 6 | 14 | 23 |
| Annualized rate, per 1,000 individuals (95% CI) | 11.7 (3.8–36.5) | 18.8 (8.4–41.9) | 21.7 (12.8–36.6) | 26.7 (17.7–40.5) |
Risk factor profiles by decade for diabetes and no diabetes (ages 40–55 years)
| 1970s | 1980s | 1990s | 2000s | |
|---|---|---|---|---|
| Diabetes, | 30 | 52 | 80 | 55 |
| Age, years | 46 (3.1) | 49 (4.8) | 48 (4.3) | 47 (3.9) |
| Percent women | 43.3 | 46.2 | 40.0 | 34.6 |
| BMI, kg/m2 | 29.6 (4.2) | 29.7 (4.8) | 31.3 (6.5) | 32.9 (6.6) |
| Overweight, % | 56.7 | 50.0 | 37.5 | 25.5 |
| Obesity, % | 36.7 | 34.6 | 53.8 | 63.6 |
| Current smoking, % | 40.0 | 44.2 | 32.5 | 14.6 |
| Systolic blood pressure, mmHg | 135 (13.2) | 131 (14.4) | 131 (14.6) | 129 (15.6) |
| Hypertension, % | 63.3 | 50.0 | 46.3 | 45.5 |
| Antihypertension treatment, % | 20.0 | 30.8 | 20.0 | 30.9 |
| Total cholesterol, mg/dL | 217 (43.9) | 220 (37.0) | 200 (34.8) | 200 (35.3) |
| Lipid-lowering treatment, % | 0.0 | 0.0 | 3.8 | 14.6 |
| No diabetes, | 1,278 | 1,499 | 1,583 | 1,637 |
| Age, years | 46 (4.1) | 47 (4.7) | 47 (4.4) | 46 (4.1) |
| Percent women | 50.3 | 50.8 | 52.4 | 53.2 |
| BMI, kg/m2 | 25.9 (3.8) | 25.7 (4.0) | 26.5 (4.5) | 26.9 (5.2) |
| Overweight, % | 41.1 | 38.6 | 39.4 | 38.1 |
| Obesity, % | 13.3 | 13.9 | 18.6 | 22.5 |
| Current smoking, % | 39.5 | 34.6 | 24.5 | 13.9 |
| Systolic blood pressure, mmHg | 126 (16.6) | 123 (15.2) | 122 (15.4) | 118 (14.4) |
| Hypertension, % | 28.1 | 23.8 | 24.8 | 21.9 |
| Antihypertension treatment, % | 5.5 | 9.9 | 9.2 | 12.0 |
| Total cholesterol, mg/dL | 211 (36.5) | 210 (36.6) | 203 (37.0) | 195 (33.8) |
| Lipid-lowering treatment, % | 1.1 | 0.8 | 2.0 | 10.8 |
Continuous data are shown as mean (SD).